Trial of AMSA in acute leukemia
Dupont, J.C.; Garay, G.E.; Scaghone, C.; Pavlovsky, S.; Woodley, P.V.
Cancer Treatment Reports 66(7): 1596-1597
1982
ISSN/ISBN: 0361-5960 PMID: 7046933 Document Number: 187501
Document emailed within 1 workday
Related Documents
Jehn, U.; Heinemann, V.; Wilmanns, W. 1989: Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogenous leukemia (AML) Anticancer Research 9(1): 119-124Latagliata, R.; Petti, M.C.; Spiriti, M.A.; Meloni, G.; Sgadari, C.; Torromeo, C.; Vegna, M.L.; Mandelli, F. 1990: High doses of ara-C and m-AMSA in the treatment of refractory acute non lymphocytic leukemia Haematologica 75(3): 249-251
Asou, N.; Adachi, K.; Tamura, J.; Kanamaru, A.; Kageyama, S.; Hiraoka, A.; Omoto, E.; Akiyama, H.; Ohno, R. 2000: Treatment of acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy--multicenter trial of the Japan Adult Leukemia Study Group (JALSG) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(8): 1168-1173
Ohino, R.; Ueda, R.; Imai Kato, Y.; Watanabe, E.; Morishima, Y.; Yokomaku, S.; Kobayashi, M.; Takeyama, H.; Ezaki, K.; Kawashima, K.; Hirano, M.; Ohara, K.; Kosaki, T.; Yoshikawa, S.; Yamada, K. 1978: A clinical trial of cell-wall skeleton of BCG in chemoimmunotherapy of acute leukemia Gan 69(2): 179-186
Bernard, J.; Jacquillat, C.; Boiron, M.; Weil, M.; Gémon, M.F.; Izrael, V.; Schaison, G.; Delobel, J. 1972: 57 cases of acute leukemia. Trial treatment with a semisynthetic daunorubicin derivative: 22,050 R.P La Nouvelle Presse Medicale 1(33): 2149-2152
Audebert, A.A.; Zylberait, D.; Krulik, M.; Debray, J. 1979: Headache following intrathecal therapy in acute leukemia: trial of tiapride as a symptomatic treatment La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(19-20): 993-997
Polli, E.E. 1978: Results of the therapy of acute leukemia. A cooperative trial by the Italian Association Against Leukemias Israel Journal of Medical Sciences 14(12): 1203-1211
Liu, Y.; Ke, X.-y.; Ma, J.; Shen, Z.-x.; Zhang, X.-h.; Du, X.; Zhao, Y.-m.; Lv, J.-q.; Zhan, Z.-m.; Zeng, X.-y.; Xu, X.-h.; Lu, Z.-s. 2006: Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia Zhonghua Zhong Liu Za Zhi 28(9): 706-708
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Vogler, W.R.; Velez-Garcia, E.; Omura, G.; Raney, M. 1989: A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia Seminars in Oncology 16(1 Suppl 2: 21-24
Ringdén, O.; Labopin, M.; Gluckman, E.; Reiffers, J.; Vernant, J.P.; Jouet, J.P.; Harrousseau, J.L.; Fiere, D.; Bacigalupo, A.; Frassoni, F.; Gorin, N.C. 1996: Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin a combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplantation 18(5): 921-929
Amrein, P.C.; Coleman, M.; Richards, F.; Poulin, R.F.; Bernhardt, B.; Ginsberg, S.J.; Green, M.R.; Morrison, A.; Cortes, E.; Kiang, D.; Weinberg, V.; Wood, W.C. 1982: Phase Ii study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study Cancer Treatment Reports 66(5): 1211-1213
Liu, Y.; Ke, X-yan.; Ma, J.; Shen, Z-xiang.; Zhang, X-hong.; Du, X.; Zhao, Y-ming.; Lü, J-qiao.; Zhan, Z-min.; Zeng, X-ying.; Xu, X-hua.; Lu, Z-sheng. 2005: Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia Zhonghua Zhong Liu Za Zhi 27(12): 750-752
Zittoun, R.; Mandelli, F.; Willemze, R.; de Witte, T.; Tura, S.; Ferrini, P.R.; Stryckmans, P.; Gattringer, C.; Petti, M.C.; Solbu, G. 1992: Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase IIi trial (AML8 A). the EORTC Leukemia Cooperative Group and the GIMEMA Group Leukemia 6(Suppl 2): 114-115
Vats, T.S.; Lui, V.; Trueworthy, R.; van Eys, J. 1981: Phase Ii clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study Cancer Treatment Reports 65(1-2): 121-122
Dłuzniewska, A.; Balwierz, W.; Balcerska, A.; Chybicka, A.; Kamieńska, E.; Karolczyk, G.; Karpińska-Derda, I.; Krawczuk-Rybak, M.; Kowalczyk, J.R.; Lewandowska, D.; Maciejka-Kapuścińska, L.; Kołtano, S.; Malinowska, I.; Matysiak, Mł.; Mikołajczyk, M.; Mizia-Malarz, A.; Muszyńska-Rosłan, K.; Niedźwiedzki, M.; Pohorecka, J.; Sikorska-Fic, B.; Sobol, G.; Sońta-Jakimczyk, D.; Tomaszewska, R.; Urasiński, T.; Wachowiak, J.; Wieczorek, M.; Wójcik, B.; Wysocki, M. 2010: Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia Przeglad Lekarski 67(6): 366-370
Kupsa, T.; Vasatova, M.; Karesova, I.; Zak, P.; Horacek, J.M. 2014: Baseline serum levels of multiple cytokines and adhesion molecules in patients with acute myeloid leukemia: results of a pivotal trial Experimental Oncology 36(4): 252-257
Berman, E.; Arlin, Z.A.; Gaynor, J.; Miller, W.; Gee, T.; Kempin, S.J.; Mertelsmann, R.; Andreeff, M.; Reich, L.; Nahmias, N. 1989: Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol Leukemia 3(2): 115-121
Bellido, M.; Martino, R.; Aventín, A.; Carnicer, M.J.; Rubiol, E.; López, O.; Sierra, J.; Nomdedéu, J.F. 2000: Leukemic relapse as T-acute lymphoblastic leukemia in a patient with acute myeloid leukemia and a minor T-cell clone at diagnosis Haematologica 85(10): 1083-1086